多西环素对腹主动脉瘤非侵入性治疗临床试验中动脉钙化进展的影响
在N-TA3CT试验中,261例患者随机接受多西环素100 mg每日两次或安慰剂,分析其中65例多西环素组和66例安慰剂组患者的动脉钙化进展。结果显示,多西环素组髂股动脉钙化评分年变化均值呈高于安慰剂组的趋势(322±399单位/年 vs 217±307单位/年,P=0.09),6个月时血清MMP-3和MMP-9水平变化两组间无显著差异。结论认为,在小主动脉瘤患者中,多西环素100 mg每日两次未降低循环MMP-3和MMP-9水平,也未改变动脉钙化进展。
要点
- 多西环素组髂股动脉钙化评分年变化均值322±399单位/年,安慰剂组217±307单位/年,P=0.09。
- 6个月时血清MMP-3和MMP-9水平变化两组间无显著差异。
- 小主动脉瘤患者中多西环素100 mg每日两次未改变动脉钙化进展。
核心结论
- 在小主动脉瘤患者中,多西环素100 mg每日两次未降低循环MMP-3和MMP-9水平,也未改变动脉钙化进展。
研究设计与样本
- N-TA3CT试验中261例患者随机接受多西环素100 mg每日两次或安慰剂,动脉钙化通过非增强CT测量。
- 纳入基线CT及2年研究期内至少1次随访CT的患者进行分析,最终多西环素组65例、安慰剂组66例纳入分析。
- 基线时及6个月时测量血清MMP-3和MMP-9水平。
主要发现
- 髂股动脉钙化评分年变化均值多西环素组322±399单位/年,安慰剂组217±307单位/年,P=0.09。
- 6个月时血清MMP-3和MMP-9水平变化两组间无显著差异。
- 两组基线特征相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Doxycycline has been shown to prevent arterial calcification via attenuation of matrix metalloproteinases (MMP) in preclinical models. We assessed the effects of doxycycline on progression of arterial calcification in patients enrolled in the Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA3CT). METHODS: Two hundred and sixty-one patients were randomized to 100 mg doxycycline twice daily or placebo. Arterial calcification was measured in abdominal vessels on noncontrast computed tomography scans. Patients with baseline computed tomography scan and 1 or more follow-up scans within the 2-year study were included for analysis. For individual arteries, mean change in iliofemoral artery calcification over time was calculated via linear regression. Serum MMP-3 and MMP-9 levels were measured at baseline and 6 months. RESULTS: Sixty-five patients in the doxycycline and 66 in the placebo arm were included in this analysis. Baseline characteristics between the groups were similar. The unadjusted mean change in iliofemoral calcium score per year trended toward higher values in patients treated with doxycycline compared with placebo (322 ± 399 units/year vs. 217 ± 307 units/year, P = 0.09). After 6 months, changes in serum MMP-3 and MMP-9 levels were not significantly different between study arms. CONCLUSIONS: In patients with small aortic aneurysm, treatment with doxycycline 100 mg twice daily did not decrease circulating levels of the matrix degrading enzymes MMP-3 and 9 or alter the progression of arterial calcification.
引用
- Kim TI, Kostiuk V, Olson SL, et al. Effect of Doxycycline on Progression of Arterial Calcification in the Noninvasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA(3)CT). Ann Vasc Surg. 2023. PMID: 37356652. doi:10.1016/j.avsg.2023.06.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。